Slayt 1

1
(No Transcript)
2
EVALUATION OF RA PA PATIENTS

• YEAR 2005

3
GENERAL DEMOGRAPHICSGENDER
? ? Total
RA 313 75,24 103 24,76 416
PA 120 58,82 84 40,18 204
AS 147 35,33 269 64,67 416
Total 580 55,98 456 44,02 1036
4
PATIENTS AGE GROUPS
-20 21-40 41-60 61 Mean
RA 2 0,48 48 11,53 222 53,36 144 34,61 54,71
PA 0 0 26 12,74 132 64,70 46 22,54 53,16
AS 0 0 80 19,2 281 67,5 55 13,3 49,7
Total 2 0,19 154 14,86 635 61,29 245 23,64 52,4
5

• DURATION OF DISEASE AGE

-10 11-20 21-30 31 Mean
RA 188 45,19 143 34,37 53 12,74 32 7,69 14,17
PA 78 38,23 91 44,6 22 10,78 13 6,37 14,08
AS 122 29,3 156 37,5 101 24,3 37 8,9 16,9
Total 388 37,45 390 37,64 176 16,98 82 7,91 15,25
6
DIFFERENCE OF MS AT POSTTREATMENT
MS1 - MS2 Dec Inc Same
RA-PA 512 82,58 13 2,09 95 15,32
MEAN MS1 MS2
RA-PA 54,41 20,66
7
DIFFERENCE OF VAS (PAIN)AT POSTTREATMENT
VAS1 - VAS2 (pain) Dec Inc Same
RA-PA 573 92,41 40 6,45 7 1,12
MEAN VAS1 VAS2
RA-PA 47,93 18,1
8
DIFFERENCE OF OWB AT POSTTREATMENT
OWB1 - OWB2 Dec Inc Same
RA-PA 575 92,74 34 5,48 11 1,77
MEAN OWB1 OWB2
RA-PA 51,18 19,05
9
DIFFERENCE OF MHAQ AT POSTTREATMENT
MHAQ1 - MHAQ2 Dec Inc Same
RA-PA 506 81,61 31 5 83 13,38
MEAN MHAQ1 MHAQ2
RA-PA 16,11 12,35
10
DIFFERENCE OF PaGADA AT POSTTREATMENT
PaGADA1 - PaGADA2 Dec Inc Same
RA-PA 563 90,8 45 7,25 12 1,93
MEAN PaGADA1 PaGADA2
RA-PA 47,51 19,22
11
DIFFERENCE OF TJ AT POSTTREATMENT
TJ1 - TJ2 Dec Inc Same
RA-PA 556 89,67 12 1,93 52 8,38
MEAN TJ1 TJ2
RA-PA 8,74 2,24
12
DIFFERENCE OF SwJ AT POSTTREATMENT
SwJ1 - SwJ2 Dec Inc Same
RA-PA 90 14,51 15 2,41 515 83,06
MEAN SwJ1 SwJ2
RA-PA 0,75 0,29
13
DIFFERENCE OF PGADA AT POSTTREATMENT
PGADA1 - PGADA2 Dec Inc Same
RA-PA 598 96,45 10 1,61 12 1,93
MEAN PGADA1 PGADA2
RA-PA 42,48 14,93
14
DIFFERENCE OF DAS 28AT POSTTREATMENT
DAS-28 1 - DAS-28 2 Dec Inc Same
RA-PA 601 96,93 9 1,45 10 1,61
MEAN DAS-28 1 DAS-28 2
RA-PA 2,18 0,83
15
ANALGESIC USAGE AT PRETREATMENT
A A- A
RA-PA 413 66,61 207 33,38
16
DIFFERENCE OF A USAGE AT POSTTREATMENT
A Same Dec Inc Sep
RA-PA 89 42,99 71 34,29 8 3,86 39 18,84
17
NSAID USAGE AT PRETREATMENT
NSAID NSAID- NSAID
RA-PA 253 40,80 367 59,19
18
DIFFERENCE OF NSAID USAGE AT POSTTREATMENT
NS AID Same Dec Inc Sep
RA-PA 243 66,21 64 17,43 7 1,9 53 14,44
19
STEROID USAGE AT PRETREATMENT
STR STR- STR
RA-PA 484 78,06 136 21,93
20
DIFFERENCE OF STR USAGE AT POSTTREATMENT
STR Same Dec Inc Sep
RA-PA 110 80,88 14 10,29 4 2,94 8 5,88
21
USAGE OF OTHER DRUGS AT PRETREATMENT
OTH OTHER- OTHER
RA-PA 228 36,77 392 63,22
22
DIFFERENCE OF OTHER DRUGS AT POSTTREATMENT
OTH Same Dec Inc Sep
RA-PA 372 94,89 9 2,29 3 0,76 8 2,04
23
MOSTLY SEEN SECONDARY DISEASES
SEC. DIS. NO YES HT CAD DM COLD CA DEPR TROI OTH
RA-PA 272 43,87 348 56,12 94 27,01 39 11,2 24 6,89 33 9,48 10 2,87 16 4,59 56 16,09 180 51,72
24
DAILY POLICLINIC CASES
PC NO YES TRA EYE URS DER DIAR PAIN USE OTH
RA-PA 410 66,12 210 33,87 7 3,33 4 1,9 37 17,61 12 5,71 13 6,19 120 57,14 10 4,76 23 10,95
25
PATIENTS WHO WERE REFERRED TO HOSPITAL
CONSULT NO MR EYE ENT DER RHE ORT NEU
RA-PA 605 97,58 4 0,64 3 0,48 3 0,48 1 0,16 2 0,32 1 0,16 1 0,16
26

• THANK YOU
• FOR YOUR ATTENTION